Jaundice is a condition caused by the buildup of bilirubin in the body. It is a common condition that affects newborns, but can also occur in adults. Jaundice can cause yellowing of the skin and eyes, and can lead to other serious health complications if left untreated. Fortunately, there is a new hope for those suffering from jaundice: innovative treatments that can help reduce the symptoms and improve the quality of life for those affected.
Jaundice can be classified into two main types: pre-hepatic jaundice and hepatic jaundice. Pre-hepatic jaundice is caused by an increase in the breakdown of red blood cells, which leads to an increase in the amount of bilirubin in the bloodstream. Hepatic jaundice is caused by a problem with the liver, such as a blockage or damage, which prevents it from processing bilirubin correctly.
Traditionally, jaundice has been treated with medications, such as antibiotics, to reduce the symptoms and prevent complications. In addition, phototherapy, or light therapy, is often used to reduce bilirubin levels in newborns. Phototherapy involves exposing the baby to special blue lights which help to break down the bilirubin in the bloodstream. In more severe cases, a blood transfusion may be necessary to reduce the bilirubin levels.
Recently, new innovative treatments for jaundice have been developed. These treatments are designed to reduce the symptoms of jaundice and improve the quality of life for those affected. One of the most promising treatments is the use of extracorporeal photopheresis (ECP). ECP is a procedure that involves removing a small amount of the patient’s blood, exposing it to a special light, and then returning it to the patient. This process helps to break down the bilirubin in the bloodstream and reduce the symptoms of jaundice. Another innovative treatment for jaundice is the use of probiotics. Probiotics are beneficial bacteria that can help to improve the functioning of the liver and reduce the symptoms of jaundice. Probiotics can be taken orally or through a topical cream. Finally, there is the use of natural supplements. Natural supplements, such as turmeric, milk thistle, and dandelion root, can help to reduce the symptoms of jaundice and improve the functioning of the liver.
Jaundice is a common condition that can cause serious health complications if left untreated. Fortunately, there is a new hope for those suffering from jaundice: innovative treatments that can reduce the symptoms and improve the quality of life for those affected. These treatments include extracorporeal photopheresis, probiotics, and natural supplements. With the help of these treatments, those suffering from jaundice can have a brighter future.
1.
'Chemo brain' cognitive issues linked to poor lymphatic-system drainage
2.
First-Line HCC Trial's Lenvatinib-Pembrolizumab Combo Misses Target.
3.
Anti-PD-L1 Plus Targeted Agent No Better Than Chemo for Resistant NSCLC
4.
Advanced Solid Tumors May Benefit from Investigative Immunotherapy Combo.
5.
For the treatment of paroxysmal nocturnal hemoglobinuria, the FDA has approved an oral factor B inhibitor.
1.
All You Need To Know About Partial Thromboplastin Time (PTT) Test
2.
Optimizing Cancer Care: Multidisciplinary Approaches and Supportive Strategies
3.
Multimodal Data Fusion with Deep Neural Networks - Revolutionizing Oncology with Precision Cancer Diagnosis 2025
4.
Gene Signatures and Their Implications in Oncology: Decoding the Blueprint for Personalized Cancer Treatment
5.
Breakthroughs in Cancer Care: From Rare Diagnoses to Advanced and Early-Stage Treatments
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
2.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
3.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
4.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation